ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
CHMP recommends AstraZeneca’s Qtrilmet for type 2 diabetes pharmaceutical-technology
September 25, 2019The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the marketing authorisation of AstraZeneca’s Qtrilmet to treat type 2 diabetes in adults. -
EMA CHMP recommends seven medicines for approval europeanpharmaceuticalreview
September 25, 2019The EMA has suggested seven treatments to be granted marketing authorisations and also advocated indication extension for eight drugs.
Pharma Sources Insight January 2025
